Novel genomic targets in oxidant-induced vascular injury

Area of Science:

• Cardiovascular Biology
• Molecular Toxicology
• Vascular Biology

Background:

• Oxidative injury is a key factor in vascular disease pathogenesis.
• Allylamine exposure induces oxidative stress and vascular damage in animal models.
• Understanding gene expression changes is crucial for identifying therapeutic targets.

Purpose of the Study:

• To investigate the intricate relationship between oxidative injury and vascular disease.
• To identify specific genes and molecular pathways dysregulated by allylamine-induced oxidative stress.
• To explore the protective effects of N-acetyl cysteine against vascular damage.

Main Methods:

• Male Sprague-Dawley rats were treated with allylamine (35 or 70 mg/kg).
• Vascular gene expression was analyzed using transcriptional profiling, immunohistochemistry, and in situ hybridization.
• Cultured aortic smooth muscle cells were used to examine molecular mechanisms.
• Reactive oxygen species (ROS) production and glutathione homeostasis were assessed.

Main Results:

• Allylamine treatment led to vascular lesions, remodeling, and increased 8-epi-PGF2alpha production.
• Key genes in extracellular matrix (ECM), integrin, and cytoskeletal pathways were altered.
• Allylamine increased ROS formation and induced gene expression changes in cultured cells.
• N-acetyl cysteine mitigated oxidative stress and gene expression alterations.

Conclusions:

• Genes within the ECM-integrin-cytoskeletal axis and LINE are molecular targets in oxidant-induced vascular injury.
• Oxidative stress plays a significant role in the pathogenesis of vascular disease.
• N-acetyl cysteine demonstrates potential as a therapeutic agent by inhibiting oxidative stress and gene dysregulation.